Skip to main content
SpringerLink
Log in

Aggressive therapy for locoregional recurrence after mastectomy in stage II and III breast cancer patients

  • Original Articles
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

Abstract

Background: To determine if aggressive treatment of locoregional recurrence affects survival, we retrospectively analyzed the clinical outcome of 69 breast cancer patients who developed locoregional disease as their first episode of recurrence following mastectomy and adjuvant chemotherapy.

Methods: Patients were identified from among 1,707 stage II and III breast cancer patients who enrolled in five different doxorubicin-based adjuvant chemotherapy protocols at The University of Texas M. D. Anderson Cancer Center from 1975 to 1986. Sixty-nine evaluable patients who had a locoregional recurrence as the first site of relapse after mastectomy formed the study group. Multifactorial analysis of clinical and histopathological characteristics of both the primary tumor and the subsequent recurrence was performed using a logistic regression method. Survival analysis was performed using an actuarial life-table method calculated from the date of registration into the adjuvant therapy protocols.

Results: Median follow-up was 6.6 years. Two factors significantly affected survival: recurrence of disease during or after adjuvant treatment of the primary and whether the patient was rendered disease free after recurrence.

Conclusions: Stage II and III breast cancer patients who have locoregional recurrence after adjuvant chemotherapy and can be rendered disease free may have a better survival rate. Aggressive treatment of locoregional recurrence including complete surgical excision should be considered in this subgroup of patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Aberizk WJ, Silver B, Henderson IC, Cady B, Harris JR. The use of radiotherapy for treatment of isolated regional recurrence of breast cancer after mastectomy.Cancer 1986;58:1214–8.

    CAS  PubMed  Google Scholar 

  2. Bedwinek JM, Lee J, Fineberg B, Ocwieza M. Prognostic indicators in patients with isolated local-regional recurrence of breast cancer.Cancer 1981;47:2232–5.

    CAS  PubMed  Google Scholar 

  3. Chen KK, Montague ED, Oswald MJ. Results of irradiation in the treatment of loco-regional breast cancer recurrence.Cancer 1985;56:1269–73.

    CAS  PubMed  Google Scholar 

  4. Griem KL, Henderson IC, Gelman R, Ascoli D, Silver B, Recht A, Goodman RL, et al. The 5-year results of a randomized trial of adjuvant radiation therapy after chemotherapy in breast cancer patients treated with mastectomy.J Clin Oncol 1987;5:1546–55.

    CAS  PubMed  Google Scholar 

  5. Buzdar AU, McNeese MD, Hortobagyi GN, Smith TL, Kau S, Fraschini G, Hug V, et al. Is chemotherapy effective in reducing the local failure rate in patients with operable breast cancer?Cancer 1990;65:394–9.

    CAS  PubMed  Google Scholar 

  6. Fowble B, Gray R, Gilchrist K, Goodman RL, Taylor S, Tormey DC. Identification of a subgroup of patients with breast cancer and histologically positive axillary nodes receiving adjuvant chemotherapy who may benefit from post-operative radiotherapy.J Clin Oncol 1988;6:1107–17.

    CAS  PubMed  Google Scholar 

  7. Valagussa P, Bonadonna G, Veronesi U. Patterns of relapse and survival following radical mastectomy.Cancer 1978;41:1170–8.

    CAS  PubMed  Google Scholar 

  8. Crowe JP Jr, Gordon NH, Antunez AR, Shenk RR, Hubay CA, Shuck JM. Local-regional breast cancer recurrence following mastectomy.Arch Surg 1991;126:429–32.

    PubMed  Google Scholar 

  9. Janjan NA, McNeese MD, Buzdar AU, Montague ED, Oswald MJ. Management of locoregional recurrent breast cancer.Cancer 1986;58:1552–6.

    CAS  PubMed  Google Scholar 

  10. Probstfeld MR, O'Connell TX. Treatment of locally recurrent breast carcinoma.Arch Surg 1989;124:1127–30.

    CAS  PubMed  Google Scholar 

  11. Mendenhall NP, Devine JW, Mendenhall WM, Bland KI, Million RR, Copeland EM. Isolated local-regional recurrence following mastectomy for adenocarcinoma of the breast treated with radiation therapy alone or combined with surgery and/or chemotherapy.Radiother Oncol 1988;12:177–85.

    Article  CAS  PubMed  Google Scholar 

  12. Schwaibold F, Fowble BL, Solin LJ, Schultz DJ, Goodman RL. The results of radiation therapy for isolated local regional recurrence after mastectomy.Int J Radiat Oncol Biol Phys 1991;21:299–310.

    CAS  PubMed  Google Scholar 

  13. Borner M, Bacchi M, Goldhirsch A, Greiner R, Harder F, Castiglione M, Jungi WF, et al. First isolated locoregional recurrence following mastectomy for breast cancer: results of a phase III multicenter study comparing systemic treatment with observation after excision and radiation.J Clin Oncol 1994;12:2071–7.

    CAS  PubMed  Google Scholar 

  14. Halverson KJ, Perez CA, Kuske RR, Garcia DM, Simpson JR, Fineberg B. Survival following locoregional recurrence of breast cancer: univariate and multivariate analysis.Int J Radiat Oncol Biol Phys 1992;23:285–91.

    CAS  PubMed  Google Scholar 

  15. Buzdar AU, Hortobagyi GN, Kau S-W, et al. Breast cancer adjuvant therapy at the M. D. Anderson Cancer Center — results of four prospective studies. In: Salmon SE, ed.Adjuvant therapy of cancer VII. Philadelphia: JB Lippincott, 1993:220–5.

    Google Scholar 

  16. Buzdar AU, Blumenschein GR, Gutterman JU, Tashima CK, Hortobagyi GN, Smith TL, Campos LT, et al. Postoperative adjuvant chemotherapy with 5-fluorouracil, doxorubicin, cyclophosphamide, and BCG vaccine: a follow-up report.JAMA 1979;242:1509–13.

    Article  CAS  PubMed  Google Scholar 

  17. Buzdar AU, Blumenschein GR, Smith TL, Powell KC, Hortobagyi GN, Yap HY, Schell FC, et al. Adjuvant chemotherapy with 5-fluorouracil, doxorubicin, and cyclophosphamide with or without bacillus Calmette-Guèrin and with or without XRT in operable breast cancer: a randomized trial.Cancer 1984;53:384–9.

    CAS  PubMed  Google Scholar 

  18. Buzdar AU, Hortobagyi GN, Kau S-W, Smith TL, Fraschini G, Holmes FA, Hug V, et al. Doxorubicin-containing adjuvant therapy for patients with stage II breast cancer: M. D. Anderson Cancer Center experience. In: Salmon SE, ed.Adjuvant therapy of cancer VI. Philadelphia: WB Saunders, 1990:210–5.

    Google Scholar 

  19. American Joint Committee on Cancer.Manual for staging of cancer, 2nd ed. Philadelphia: JB Lippincott, 1978.

    Google Scholar 

  20. Black MM, Kwon S. Prognostic factors in breast cancer. In: Gallager HG, Leis HP Jr, Synderman RK, Urban JA, eds.The breast. St. Louis: CV Mosby, 1978:297.

    Google Scholar 

  21. Gehan EA. Estimating survival functions from the life table.J Chron Dis 1969;21:629–44.

    Article  CAS  PubMed  Google Scholar 

  22. Gelman R, Gelber R, Henderson IC, Coleman CN, Harris JR. Improved methodology for analyzing local and distant recurrence.J Clin Oncol 1990;8:548–55.

    CAS  PubMed  Google Scholar 

  23. Dunphy FR, Spitzer G, Buzdar AU, Hortobagyi GN, Horwitz LJ, Yau JC, Spinolo JA, et al. Treatment of estrogen receptor negative or hormonally refractory breast cancer with double high-dose chemotherapy intensification and bone marrow support.J Clin Oncol 1990;8:1207–16.

    CAS  PubMed  Google Scholar 

  24. Hortobagyi GN. Overview of new treatments for breast cancer.Breast Cancer Res Treat 1992;21:3–13.

    Article  CAS  PubMed  Google Scholar 

  25. Rowinsky EK, Casenave LA, Donehower RC. Taxol: a novel investigational antimicrotubule agent.J Natl Cancer Inst 1990;82:1247–59.

    CAS  PubMed  Google Scholar 

  26. Holmes FA, Walters RS, Theriault RL, Forman AD, Newton LK, Raber MN, Buzdar AU, et al. Phase II trial of taxol, an active drug in the treatment of metastatic breast cancer.J Natl Cancer Inst 1991;83:1797–805.

    CAS  PubMed  Google Scholar 

  27. Pazdur R, Kudelka AP, Kavanagh JJ, Cohen PR, Raber MN. The taxoids: paclitaxel (taxol) and docetaxel (taxotere).Cancer Treat Rev 1993;19:351–86.

    Article  CAS  PubMed  Google Scholar 

  28. Kiang DT, Kennedy BJ. Tamoxifen (antiestrogen) therapy in advanced breast cancer.Ann Intern Med 1977;87:687–90.

    CAS  PubMed  Google Scholar 

  29. Manni A, Santen R, Harvey H, Lipton A, Max D. Treatment of breast cancer with gonadotrophin-releasing hormone.Endocr Rev 1986;7:89–94.

    CAS  PubMed  Google Scholar 

  30. Pierce LJ, Lichter AS, Archer P. Indications, integration, and technical aspects of local-regional irradiation in the management of advanced breast cancer.Semin Radiat Oncol 1994;4:242–53.

    PubMed  Google Scholar 

  31. Kroll SS, Walsh G, Ryan B, King RC. Risks and benefits of using Marlex mesh in chest wall reconstruction.Ann Plast Surg 1993;31:303–6.

    CAS  PubMed  Google Scholar 

  32. McCormack PM, Bains MS, Burt ME, Martini N, Chaglassian T, Hidalgo DA. Recurrent mammary carcinoma failing multimodality therapy.Arch Surg 1989;124:158–61.

    CAS  PubMed  Google Scholar 

  33. Singletary SE. Surgical management of locally advanced breast cancer.Semin Radiat Oncol 1994;4:254–9.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Surgical Breast Service, Department of Surgical Oncology, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, Box 106, 77030, Houston, TX, USA

    Edna M. Mora MD &  S. Eva Singletary MD

  2. the Department of Breast Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, USA

    Aman U. Buzdar MD

  3. the Department of Biomathematics, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, USA

    Dennis A. Johnston PhD

Authors
  1. Edna M. Mora MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. S. Eva Singletary MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Aman U. Buzdar MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Dennis A. Johnston PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Mora, E.M., Singletary, S.E., Buzdar, A.U. et al. Aggressive therapy for locoregional recurrence after mastectomy in stage II and III breast cancer patients. Annals of Surgical Oncology 3, 162–168 (1996). https://doi.org/10.1007/BF02305796

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02305796

Key Words

Search

Navigation